In our laboratory we have developed chemical vectors to deliver polyIC to EGFR-overexpressing glioblastoma [32], breast cancer and vulval carcinoma [14], as well as HER-2-overexpressing breast cancer [33]. The gene discussed is EGFR; the disease is breast cancer.